A History of the Chronic Leukemias

Piller G. The history of leukemia: a personal perspective. Blood Cells. 1993;19:521.PubMed

Velpeau A. Sur la resorption du puseat sur l’altération du sang dans les maladies clinique de persection nenemant. Premier observation. Rev Med. 1827;2:216.

Donne A. De l’origine des globules du sang, de leur mode de formation, de leur fin. C R Acad Sci. 1842;14:366.

Bennett’s JH. Case of hypertrophy of the spleen and liver in which death took place from suppuration of the blood. Edinb Med Surg J. 1845;64:413.

Virchow R. Weisses Blut. Frorieps Notizen. 1845;36:151.

Fuller H. Particulars of a case in which enormous enlargement of the spleen and liver, together with dilatation of all vessels in the body were found coincident with a peculiarly altered condition of the blood. Lancet. 1846;ii:43.

Virchow R. Weisses Blut und Milztumoren. Med Z. 1846;15:157.

10.

Wood GB. Trans Coll Physicians. Philadelphia. p. 265. 1850–52.

11.

Virchow R. Zur pathologischen Physiologie des Bluts: Die Bedeutung der milz- und Lymph-Drusen-Krankheiten fur die Blutmischung (Leukaemia). Virchows Arch. 1853;5:43.CrossRef

12.

Neumann E. Ein Fall von Leukamie mit Erkrankung des Knochenmarkes. Arch Heilk. 1870;11:1.

13.

Ebstein W. Ueber die acute Leukamie und Pseudoleukamie. Deut Arch Klin Med. 1889;44:343.

14.

Ehrlich P. Parbenanalytische Untersuchungen zur Histologie und Klinik des Blutes. Berlin: Hirschwald; 1891.

15.

Neumann E. Uber myelogene Leukamie. Berliner Klin Wochenschr. 1878;15:69.

16.

Naegeli O. Uber rothes Knochenmark und Myeloblasten. Deut Med Wochenschr. 1900;18:287.CrossRef

17.

Turk W. Ein System der Lymphomatosen. Wien Klin Wochenschr. 1903;16:1073.

18.

Bernard J. L’erythroleucemie experimentale provoquée par les injections intramedullaires du goudron. Sang. 1934;8:28.

19.

Storti E. Modifications morphologiques du sang et des organes hematopoietiques provoquées chez le rat blanc par injections intramedullaires de 1–2 benzopyrene. Sang. 1937;11:7.

20.

Nowell PC, Hungerford DA. A minute chromosome in human granulocytic leukemia. Science. 1960;132:1497.

21.

Fialkow PJ, Martin PJ, Najfeld V, Penfold GK, Jacobson RJ, Hansen JA. Evidence for a multistep pathogenesis of chronic myelogenous leukemia. Blood. 1981;58:159.

22.

Stryckmans PA, Debusscher L, Collard E. Cell kinetics in chronic granulocytic leukaemia (CGL). Clin Haematol. 1977;6:21.PubMed

23.

Pederson B. Kinetics and cell function. In: Shaw MT, editor. Chronic granulocytic leukaemia. Eastbourne UK: Praeger; 1982. p. 93.

24.

De Klein A, van Kessel A, Grosveld G, Bartram CR, Hagemeijer A, Bootsma D, Spurr NK, Heisterkamp N, Groffen J, Stephenson JR. A cellular oncogene is translocated to the Philadelphia chromosome in chronic myelocytic leukaemia. Nature. 1982;300:765.PubMedCrossRef

25.

Groffen J, Heisterkamp N, Stephenson JR, van Kessel A, de Klein A, Grosveld G, Bootsma D. c-sis is translocated from chromosome 22 to chromosome 9 in chronic myelocytic leukemia. J Exp Med. 1983;158:9.PubMedCrossRef

26.

Ben-Neriah Y, Daley GQ, Mes-Masson A-M, Witte ON, Baltimore D. The chronic myelogenous leukemia specific p210 protein is the product of the bcr/abl hybrid gene. Science. 1986;223:212.CrossRef

27.

Lee M-S, Stass SA. Detection of chimeric bcr-abl mRNA and minimal residual disease by polymerase chain reaction. Hematology. 1991;13:241.

28.

Marley SB, Gordon MY. Chronic myeloid leukaemia: stem cell derived but progenitor driven. Clin Sci (Lond). 2005;109:13.CrossRef

29.

Jamieson CH, Ailles LE, Dylla SJ, Muijtjens M, Jones C, Zehnder JL, Gotlib J, Li K, Keating A, Sawyers CL, Weissman IL. Granulocyte-macrophage progenitor cells as candidate leukemic stem cells in blast-crisis CML. N Engl J Med. 2004;351:657.PubMedCrossRef

30.

Bedi A, Zehnbauer BA, Sharkis SJ, Jones RJ. Inhibition of apoptosis by BCR-ABL in chronic myeloid leukemia. Blood. 1994;15:2038.

31.

Amos TA, Lewis JL, Grand FH, Gooding RP, Goldman JM, Gordon MY. Apoptosis in chronic myeloid leukaemia: normal responses by progenitor cells to growth factor deprivation, X-irradiation and glucocorticoids. Br J Haematol. 1995;91:387.PubMedCrossRef

32.

Gordon MY, Dowding CR, Riley GP, Goldman JM, Greaves MF. Altered adhesive interactions with marrow stroma of haematopoietic progenitor cells in chronic myeloid leukaemia. Nature. 1987;328:342.PubMedCrossRef

33.

Osler W. Leukaemia. In: The principles and practice of medicine, 7th ed. New York: Appleton; 1909. p. 731

34.

Minot B, Isaacs R. Lymphatic leukemia: age, incidence, duration and benefit derived from irradiation. Boston Med Surg J. 1924;191:1.CrossRef

35.

Rai KR. Progress in chronic lymphocytic leukaemia: a historical perspective. Baillieres Clin Haematol. 1993;6:757.PubMedCrossRef

36.

Galton DAG. The pathogenesis of chronic lymphocytic leukaemia. Can Med Assoc J. 1966;94:1005.PubMed

37.

Dameshek W. Chronic lymphocytic leukemia—an accumulative disease of immunologically incompetent lymphocytes. Blood. 1967;29:566.PubMed

38.

Dormer P, Theml H, Lau B. Chronic lymphocytic leukaemia: a proliferative or accumulative disorder? Leuk Res. 1983;7:1.PubMedCrossRef

39.

Hockenberry DM, Oltvai ZN, Yin X-M, Milliman CC, Korsmeyer SJ. Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell. 1993;75:241.CrossRef

Only gold members can continue reading. Log In or Register to continue